CLINICAL_TRIALS
trial_result
· 2023-02-15
Clinical Trial Update: Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients [Phase 4]
Summary
Phase 4 trial assessing how moderate-intensity physical activity affects PK-guided extended half-life factor VIII concentrates for prophylaxis in severe hemophi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Chulalongkorn University | Conditions: Hemophilia | Phase 4 | Status: COMPLETED